Annual CAPEX
$4.98 M
-$8.93 M-64.19%
31 December 2023
Summary:
ADMA Biologics annual capital expenditures is currently $4.98 million, with the most recent change of -$8.93 million (-64.19%) on 31 December 2023. During the last 3 years, it has fallen by -$8.53 million (-63.13%). ADMA annual CAPEX is now -64.19% below its all-time high of $13.91 million, reached on 31 December 2022.ADMA CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$1.10 M
-$1.27 M-53.57%
30 September 2024
Summary:
ADMA Biologics quarterly capital expenditures is currently $1.10 million, with the most recent change of -$1.27 million (-53.57%) on 30 September 2024. Over the past year, it has dropped by -$309.00 thousand (-21.96%). ADMA quarterly CAPEX is now -75.47% below its all-time high of $4.48 million, reached on 30 June 2021.ADMA Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$7.23 M
+$341.00 K+4.95%
30 September 2024
Summary:
ADMA Biologics TTM capital expenditures is currently $7.23 million, with the most recent change of +$341.00 thousand (+4.95%) on 30 September 2024. Over the past year, it has increased by +$2.25 million (+45.19%). ADMA TTM CAPEX is now -48.01% below its all-time high of $13.91 million, reached on 31 December 2022.ADMA TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMA CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -22.0% | +45.2% |
| 3 y3 years | -63.1% | -70.1% | -46.5% |
| 5 y5 years | +30.7% | -31.1% | +89.7% |
ADMA CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -64.2% | at low | -72.1% | +45.0% | -48.0% | +45.2% |
| 5 y | 5 years | -64.2% | +30.7% | -75.5% | +45.0% | -48.0% | +89.7% |
| alltime | all time | -64.2% | >+9999.0% | -75.5% | >+9999.0% | -48.0% | >+9999.0% |
ADMA Biologics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.10 M(-53.6%) | $7.23 M(+4.9%) |
| June 2024 | - | $2.37 M(+0.1%) | $6.89 M(+27.7%) |
| Mar 2024 | - | $2.36 M(+67.9%) | $5.40 M(+8.4%) |
| Dec 2023 | $4.98 M(-64.2%) | $1.41 M(+85.9%) | $4.98 M(-32.0%) |
| Sept 2023 | - | $757.00 K(-13.2%) | $7.32 M(-26.4%) |
| June 2023 | - | $872.00 K(-55.2%) | $9.95 M(-23.6%) |
| Mar 2023 | - | $1.95 M(-48.1%) | $13.01 M(-6.4%) |
| Dec 2022 | $13.91 M(+3.0%) | $3.75 M(+10.9%) | $13.91 M(+0.5%) |
| Sept 2022 | - | $3.38 M(-14.2%) | $13.84 M(+4.5%) |
| June 2022 | - | $3.94 M(+38.6%) | $13.25 M(-3.9%) |
| Mar 2022 | - | $2.84 M(-22.7%) | $13.78 M(+2.0%) |
| Dec 2021 | $13.51 M(+6.2%) | $3.68 M(+31.8%) | $13.51 M(+0.6%) |
| Sept 2021 | - | $2.79 M(-37.7%) | $13.43 M(-0.7%) |
| June 2021 | - | $4.48 M(+74.1%) | $13.53 M(+2.3%) |
| Mar 2021 | - | $2.57 M(-28.5%) | $13.22 M(+3.9%) |
| Dec 2020 | $12.73 M(+233.9%) | $3.60 M(+24.7%) | $12.73 M(+18.7%) |
| Sept 2020 | - | $2.89 M(-30.8%) | $10.72 M(+9.3%) |
| June 2020 | - | $4.17 M(+100.9%) | $9.81 M(+69.8%) |
| Mar 2020 | - | $2.07 M(+30.1%) | $5.78 M(+51.5%) |
| Dec 2019 | $3.81 M(+81.9%) | $1.59 M(-19.1%) | $3.81 M(+25.5%) |
| Sept 2019 | - | $1.97 M(+1358.5%) | $3.04 M(+134.5%) |
| June 2019 | - | $135.20 K(+22.4%) | $1.29 M(-21.8%) |
| Mar 2019 | - | $110.50 K(-86.5%) | $1.66 M(-20.9%) |
| Dec 2018 | $2.10 M | $819.00 K(+255.8%) | $2.10 M(-36.2%) |
| Sept 2018 | - | $230.20 K(-53.7%) | $3.29 M(-9.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $497.10 K(-9.5%) | $3.63 M(+12.5%) |
| Mar 2018 | - | $549.20 K(-72.7%) | $3.22 M(+20.4%) |
| Dec 2017 | $2.68 M(+3546.2%) | $2.01 M(+252.7%) | $2.68 M(+295.6%) |
| Sept 2017 | - | $569.90 K(+512.8%) | $676.50 K(+504.0%) |
| June 2017 | - | $93.00 K(+2483.3%) | $112.00 K(+87.9%) |
| Mar 2017 | - | $3600.00(-64.0%) | $59.60 K(-18.8%) |
| Dec 2016 | $73.40 K(+181.2%) | $10.00 K(+85.2%) | $73.40 K(+24.6%) |
| Sept 2016 | - | $5400.00(-86.7%) | $58.90 K(-5.6%) |
| June 2016 | - | $40.60 K(+133.3%) | $62.40 K(+113.0%) |
| Mar 2016 | - | $17.40 K(-486.7%) | $29.30 K(+12.3%) |
| Dec 2015 | $26.10 K(-98.9%) | -$4500.00(-150.6%) | $26.10 K(-95.6%) |
| Sept 2015 | - | $8900.00(+18.7%) | $586.90 K(-70.3%) |
| June 2015 | - | $7500.00(-47.2%) | $1.97 M(-11.3%) |
| Mar 2015 | - | $14.20 K(-97.4%) | $2.23 M(-4.2%) |
| Dec 2014 | $2.32 M(+1081.7%) | $556.30 K(-60.2%) | $2.32 M(+31.1%) |
| Sept 2014 | - | $1.40 M(+440.2%) | $1.77 M(+351.8%) |
| June 2014 | - | $258.50 K(+131.0%) | $392.30 K(+61.8%) |
| Mar 2014 | - | $111.90 K(+1934.5%) | $242.50 K(+23.3%) |
| Dec 2013 | $196.60 K(+65.3%) | $5500.00(-66.5%) | $196.70 K(-13.2%) |
| Sept 2013 | - | $16.40 K(-84.9%) | $226.50 K(-4.6%) |
| June 2013 | - | $108.70 K(+64.4%) | $237.50 K(+28.4%) |
| Mar 2013 | - | $66.10 K(+87.3%) | $185.00 K(+55.6%) |
| Dec 2012 | $118.90 K | $35.30 K(+28.8%) | $118.90 K(+42.2%) |
| Sept 2012 | - | $27.40 K(-51.2%) | $83.60 K(+48.8%) |
| June 2012 | - | $56.20 K | $56.20 K |
FAQ
- What is ADMA Biologics annual capital expenditures?
- What is the all time high annual CAPEX for ADMA Biologics?
- What is ADMA Biologics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for ADMA Biologics?
- What is ADMA Biologics quarterly CAPEX year-on-year change?
- What is ADMA Biologics TTM capital expenditures?
- What is the all time high TTM CAPEX for ADMA Biologics?
- What is ADMA Biologics TTM CAPEX year-on-year change?
What is ADMA Biologics annual capital expenditures?
The current annual CAPEX of ADMA is $4.98 M
What is the all time high annual CAPEX for ADMA Biologics?
ADMA Biologics all-time high annual capital expenditures is $13.91 M
What is ADMA Biologics quarterly capital expenditures?
The current quarterly CAPEX of ADMA is $1.10 M
What is the all time high quarterly CAPEX for ADMA Biologics?
ADMA Biologics all-time high quarterly capital expenditures is $4.48 M
What is ADMA Biologics quarterly CAPEX year-on-year change?
Over the past year, ADMA quarterly capital expenditures has changed by -$309.00 K (-21.96%)
What is ADMA Biologics TTM capital expenditures?
The current TTM CAPEX of ADMA is $7.23 M
What is the all time high TTM CAPEX for ADMA Biologics?
ADMA Biologics all-time high TTM capital expenditures is $13.91 M
What is ADMA Biologics TTM CAPEX year-on-year change?
Over the past year, ADMA TTM capital expenditures has changed by +$2.25 M (+45.19%)